Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. F. Mühlradt
Intratumoural Injection of the Toll-Like Receptor-2/6 Agonist ‘Macrophage-Activating Lipopeptide-2’ in Patients With Pancreatic Carcinoma: A Phase I/Ii Trial
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Monoacyl Lipopeptide Agonist of Toll-Like Receptor 2 (TLR2) as a Vaccine Adjuvant
Science-Business eXchange
FSL-1, a Bacterial-Derived Toll-Like Receptor 2/6 Agonist, Enhances Resistance to Experimental HSV-2 Infection
Virology Journal
Virology
Infectious Diseases
Phase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 With and Following Rituximab in Patients With Recurrent Indolent and Aggressive Non Hodgkin's Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Toll-Like Receptor 2 (TLR2)
Science-Business eXchange
Perioperative Immunomodulation With Interleukin-2 in Patients With Renal Cell Carcinoma: Results of a Controlled Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Pilot Study of Intratumoral G100, Toll-Like Receptor-4 (TLR4) Agonist, Therapy in Patients With Merkel Cell Carcinoma (MCC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Polymorphisms Within the Toll-Like Receptor (TLR)-2, -4, and -6 Genes in Cattle
Diversity
Ecology
Nature
Biological Sciences
Landscape Conservation
Agricultural
Ecological Modeling
The Association Between Toll-Like Receptor 2 Single-Nucleotide Polymorphisms and Hepatocellular Carcinoma Susceptibility
BMC Cancer
Cancer Research
Oncology
Genetics
Campylobacter Jejuni Drives MyD88-Independent Interleukin-6 Secretion via Toll-Like Receptor 2
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
